Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02335411
Brief Title: A Study of Pembrolizumab (MK-3475) in Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-059/KEYNOTE-059)

First Submitted : January 7, 2015
First Submitted that Met QC Criteria : January 7, 2015
First Posted : January 9, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : April 3, 2019
Last Update Posted : April 5, 2019